Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2026-03-03 @ 7:39 PM
Study NCT ID:
NCT02464657
Status:
COMPLETED
Last Update Posted:
2021-10-07
First Post:
2015-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-03
First Submit QC Date:
None
Study First Post Date:
2015-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-08
Results First Submit QC Date:
None
Results First Post Date:
2021-10-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-09
Last Update Post Date:
2021-10-07
Last Update Post Date Type:
ACTUAL